Stem cell transplantation for neurodegenerative diseases

Current Opinion in Neurology

Volumn 20, Issue 6, 2007, Pages 688-692

  Rosser, Anne E ^a,b   Zietlow, Rike ^b   Dunnett, Stephen B ^b  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Neural precursors; Neural transplantation; Neurodegeneration; Stem cells

Indexed keywords

DOPAMINE; NEUROTROPHIN; TYROSINE 3 MONOOXYGENASE;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; BASAL GANGLION; BONE MARROW TRANSPLANTATION; CELL DIFFERENTIATION; DEGENERATIVE DISEASE; DEMYELINATING DISEASE; EMBRYONIC STEM CELL; HUMAN; HUNTINGTON CHOREA; MESENCEPHALON; MESENCHYME CELL; MOTONEURON; MULTIPLE SCLEROSIS; NEURAL STEM CELL; NIEMANN PICK DISEASE; NONHUMAN; PARKINSON DISEASE; REVIEW; STEM CELL TRANSPLANTATION;

ANIMALS; BRAIN NEOPLASMS; CELL DIFFERENTIATION; CELL LINEAGE; DOPAMINE; HUMANS; NERVE GROWTH FACTORS; NEURODEGENERATIVE DISEASES; PHENOTYPE; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 36049010922     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/WCO.0b013e3282f132fc     Document Type: Review

References (47)

1. Papaioannou VE, McBurney MW, Gardner RL, Evans MJ. Fate of teratocarcinoma cells injected into early mouse embryos. Nature 1975; 258:70-73.
2. Potten CS, Loeffler M. Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt. Development 1990; 110:1001-1020.
3. Lensch MW, Daheron L, Schlaeger TM. Pluripotent stem cells and their niches. Stem Cell Rev 2006; 2:185-202.
4. Conti L, Cataudella T, Cattaneo E. Neural stem cells: a pharmacological tool for brain diseases? Pharmacol Res 2003; 47:289-297.
5. Nern C, Momma S. The realized niche of adult neural stem cells. Stem Cell Rev 2006; 2:233-240. This article reviews the concept of the stem cell niche.
6. Krabbe C, Zimmer J, Meyer M. Neural transdifferentiation of mesenchymal stem cells-a critical review. AOMIS 2005; 113:831-844.
7. Weiss ML, Troyer DL. Stem cells in the umbilical cord. Stem Cell Rev 2006; 2:155-162.
8. Tsai MS, Hwang SM, Tsai YL, et al. Clonal amniotic fluid-derived stem cells express characteristics of both mesenchymal and neural stem cells. Biol Reprod 2006; 74:545-551.
9. Dunnett SB, Björklund A (editors). Functional neural transplantation II. Novel cell therapies for CNS disorders. Amsterdam: Elsevier Science; 2000.
10. Lindvall O, Björklund A. Cell therapy in Parkinson's disease. NeuroRx 2004; 1:382-393.
11. Caldwell MA, He X, Wilkie N, et al. Growth factors regulate the survival and fate of cells derived from human neurospheres. Nat Biotechnol 2001; 19:475-479.
12. Cesnulevicius K, Timmer M, Wesemann M, et al. Nucleofection is the most efficient nonviral transfection method for neuronal stem cells derived from ventral mesencephali with no changes in cell composition or dopaminergic fate. Stem Cells 2006; 24:2776-2791.
13. Andersson EK, Irvin DK, Ahlsiö J, Parmar M. Ngn2 and Nurr1 act in synergy to induce midbrain dopaminergic neurons from expanded neural stem and progenitor cells. Exp Cell Res 2007; 313:1172-1180. This paper describes the synergistic use of two important transcriptomic factors in directed dopamine differentiation.
14. Anderson L, Burnstein RM, He X, et al. Gene expression changes in long term expanded human neural progenitor cells passaged by chopping lead to loss of neurogenic potential in vivo. Exp Neurol 2007; 204:512-524.
15. Joannides AJ, Webber DJ, Raineteau O, et al. Environmental signals regulate lineage choice and temporal maturation of neural stem cells from human embryonic stem cells. Brain 2007; 130:1263-1275.
16. Bouhon IA, Joannides A, Kato H, et al. Embryonic stem cell-derived neural progenitors display temporal restriction to neural patterning. Stem Cells 2006; 24:1908-1913. This paper characterizes some of the in-vitro temporal aspects important for patterning of embryonic stem cell-derived neural progenitors.
17. Rodriguez-Gomez JA, Lu JQ, Velasco I, et al. Persistent dopamine functions of neurons derived from embryonic stem cells in a rodent model of Parkinson disease. Stem Cells 2007; 25:918-928. This is the first paper to demonstrate long-term survival and functional effects of embryonic stem cell-derived neural progenitors after directed differentiation to a dopaminergic phenotype.
18. Roy NS, Cleren C, Singh SK, et al. Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes. Nat Med 2006; 12:1259-1268. This paper demonstrates convincing in-vitro dopamine differentiation of human embryonic stem cell-derived neural progenitors.
19. Christophersen NS, Brundin P. Large stem cell grafts could lead to erroneous interpretations of behavioral results? Nat Med 2007; 13:118. This article contains an important discussion about some of the potential pitfalls of assessing graft function following neural transplantation.
20. Messmer K, Remington MP, Skidmore F, Fishman PS. Induction of tyrosine hydroxylase expression by the transcription factor Pitx3. Int J Dev Neurosci 2007; 25:29-37.
21. Brederlau A, Correia AS, Anisimov SV, et al. Transplantation of human embryonic stem cell-derived cells to a rat model of Parkinson's disease: effect of in vitro differentiation on graft survival and teratoma formation. Stem Cells 2006; 24:1433-1440.
22. Chung S, Shin BS, Hedlund E, et al. Genetic selection of sox1GFP-expressing neural precursors removes residual tumorigenic pluripotent stem cells and attenuates tumor formation after transplantation. J Neurochem 2006; 97:1467-1480.
23. Bachoud-Levi AC, Gaura V, Brugieres P, et al. Effect of fetal neural transplants in patients with Huntington's disease 6 years after surgery: a long-term followup study. Lancet Neurol 2006; 5:303-309. This article provides clinical evidence of the efficacy of circuit repair in Huntington's disease.
24. Bernreuther C, Dihne M, Johann V, et al. Neural cell adhesion molecule L1-transfected embryonic stem cells promote functional recovery after excitotoxic lesion of the mouse striatum. J Neurosci 2006; 26:11532-11539.
25. Jain M, Armstrong RJ, Elneil S, Barker RA. Transplanted human neural precursor cells migrate widely but show no lesion-specific tropism in the 6-hydroxydopamine rat model of Parkinson's disease. Cell Transplant 2006; 15:579-593.
26. Julien JP. ALS: astrocytes move in as deadly neighbors. Nat Neurosci 2007; 10:535-537.
27. Lee H, Al Shamy G, Elkabetz Y, et al. Directed differentiation and transplantation of human embryonic stem cell derived motoneurons. Stem Cells 2007; 25:1931-1939. In-vitro evidence of directed differentiation of motor neurons.
28. Chandran S, Hunt D, Joannides A, et al. Myelin repair: the role of stem and precursor cells in multiple sclerosis. Philos Trans R Soc Lond B Biol Sci 2007; Feb 5 [Epub ahead of print].
29. Keirstead HS, Nistor G, Bernal G, et al. Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J Neurosci 2005; 25:4694-4705.
30. Cloutier F, Siegenthaler MM, Nistor G, Keirstead HS. Transplantation of human embryonic stem cell-derived oligodendrocyte progenitors into rat spinal cord injuries does not cause harm. Regen Med 2006; 1:469-479.
31. Joannides AJ, Fiore-Hériché C, Battersby AA, et al. A scaleable and defined system for generating neural stem cells from human embryonic stem cells. Stem Cells 2007; 25:731-737. This paper describes a cell-free and potentially GMP-compatible system.
32. Li Y, Chen J, Wang L, Zhang L, et al. Intracerebral transplantation of bone marrow stromal cells in a 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine mouse model of Parkinson's disease. Neurosci Lett 2001; 316:67-70.
33. Suon S, Yang M, Iacovitti L. Adult human bone marrow stromal spheres express neuronal traits in vitro and in a rat model of Parkinson's disease. Brain Res 2006; 1106:46-51.
34. Fallahi-Sichani M, Soleimani M, Najafi SM, et al. In vitro differentiation of cord blood unrestricted somatic stem cells expressing dopamine-associated genes into neuron-like cells. Cell Biol Int 2007; 31:299-303.
35. Fu YS, Cheng YC, Lin M, et al. Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopaminergic neurons in vitro: potential therapeutic application for Parkinsonism. Stem Cells 2006; 24:115-124.
36. Yasuhara T, Date I. Intracerebral transplantation of genetically engineered cells for Parkinson's disease: toward clinical application. Cell Transplant 2007; 16:125-132.
37. Bae JS, Han HS, Youn DH, et al. Bone marrow-derived mesenchymal stem cells promote neuronal networks with functional synaptic transmission after transplantation into mice with neurodegeneration. Stem Cells 2007; 25: 1307-1316. This study highlights potentially important cellular mechanisms.
38. Caplan AI, Dennis JE. Mesenchymal stem cells as trophic mediators. Cell Biochem 2006; 98:1076-1084.
39. Pisati F, Bossolasco P, Meregalli M, et al. Induction of neurotrophin expression via human adult mesenchymal stem cells: implication for cell therapy in neurodegenerative diseases. Cell Transplant 2007; 16:41-55.
40. Love S, Plaha P, Patel NK, et al. Glial cell line-derived neurotrophic factor induces neuronal sprouting in human brain. Nat Med 2005; 11:703-704.
41. Behrstock S, Ebert A, McHugh J, et al. Human neural progenitors deliver glial cell line-derived neurotrophic factor to parkinsonian rodents and aged primates. Gene Ther 2006; 13:379-388.
42. Pineda JR, Rubio N, Akerud P, et al. Neuroprotection by GDNF-secreting stem cells in a Huntington's disease model: optical neuroimage tracking of brain-grafted cells. Gene Ther 2007; 14:118-128.
43. Bühnemann C, Scholz A, Bernreuther C, et al. Neuronal differentiation of transplanted embryonic stem cell-derived precursors in stroke lesions of adult rats. Brain 2006; 129:3238-3248. The results of this study show electrophysiological activity within transplanted ESCs, but no functional effects on host behaviour.
44. Lee HJ, Kim KS, Park IH, Kim SU. Human neural stem cells over-expressing VEGF provide neuroprotection, angiogenesis and functional recovery in mouse stroke model. PLoS ONE 2007; 2:e156.
45. Clement AM, Nguyen MD, Roberts EA, et al. Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science 2003; 302:113-117.
46. Corti S, Locatelli F, Donadoni C, et al. Wild-type bone marrow cells ameliorate the phenotype of SOD1-G93A ALS mice and contribute to CNS, heart and skeletal muscle tissues. Brain 2004; 127:2518-2532.
47. Mazzini L, Mareschi K, Ferrero I, et al. Autologous mesenchymal stem cells: clinical applications in amyotrophic lateral sclerosis. J Neurol Res 2006; 28:523-526.